InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
2.080
+0.020 (0.97%)
Nov 22, 2024, 4:00 PM EST - Market closed
InflaRx Market Cap
InflaRx has a market cap or net worth of $122.48 million as of November 22, 2024. Its market cap has increased by 46.48% in one year.
Market Cap
122.48M
Enterprise Value
94.25M
1-Year Change
46.48%
Ranking
Category
Stock Price
$2.08
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $351.36M to $122.48M, a decrease of -65.14%. That is a compound annual growth rate of -13.90%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Telomir Pharmaceuticals | 125.55M |
Cardiff Oncology | 125.28M |
Eupraxia Pharmaceuticals | 125.04M |
Skye Bioscience | 124.99M |
Protalix BioTherapeutics | 124.44M |
Cibus | 122.41M |
Zentek | 122.01M |
Milestone Pharmaceuticals | 121.88M |